E-ISSN: 2667-4610

Archives

Volume 12, Issue 4

December 2013

Back to Archives Download Issue

Quality Of Life 3

Editorial

Bph

Metabolic syndrome in the etiology of benign prostatic hyperplasia/ lower urinary tract symptoms

Cenk M. Yazıcı

The current status of prostate-specific antigen in the management of Benign Prostatic Hyperplasia

Urodynamic studies in Benign Prostate Hyperplasia: whom and when?

Umut Gönülalan

The role of phosphodiesterase type-5 inhibitors in Benign Prostatic Hyperplasia, current approaches

Uğur Üyetürk

Prostatic inflammation as a target of etiopathogenesis and treatment

Umut Gönülalan

The combination of anticholinergics and alpha-1 receptor blockers

Yusuf Şenoğlu

Will lasers replace transurethral resection of the prostate for the treatment of BPH?

Serhat Dönmezer

Erem Kaan Başok

Long-term treatment of Benign Prostatic Hyperplasia with the combination of alpha blockers and 5-alpha reductase inhibitors

Mehmet İlteriş Tekin

Quality Of Life

The impact of control cystoscopies' on quality of life in the surveillance of bladder tumor

The comparison of the treatment alternatives on quality of life in testicular cancers

Sinharib Çitgez

Çetin Demirdağ

Does laser prostatectomy provide an advantage regarding quality of life?

Olcay Yıldırım

Pathology

Prostate cancer: New developments in pathogenesis and prognostic repercussions

Evaluation of the non-neoplastic kidney in tumor nephrectomy specimens and its significance

Ayşim Özağarı

General

Basic molecular methods used in urooncology